Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor.

Article Details

Citation

Duesbery NS, Webb CP, Leppla SH, Gordon VM, Klimpel KR, Copeland TD, Ahn NG, Oskarsson MK, Fukasawa K, Paull KD, Vande Woude GF

Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor.

Science. 1998 May 1;280(5364):734-7.

PubMed ID
9563949 [ View in PubMed
]
Abstract

Anthrax lethal toxin, produced by the bacterium Bacillus anthracis, is the major cause of death in animals infected with anthrax. One component of this toxin, lethal factor (LF), is suspected to be a metalloprotease, but no physiological substrates have been identified. Here it is shown that LF is a protease that cleaves the amino terminus of mitogen-activated protein kinase kinases 1 and 2 (MAPKK1 and MAPKK2) and that this cleavage inactivates MAPKK1 and inhibits the MAPK signal transduction pathway. The identification of a cleavage site for LF may facilitate the development of LF inhibitors.

DrugBank Data that Cites this Article

Polypeptides
NameUniProt ID
Dual specificity mitogen-activated protein kinase kinase 1Q02750Details
Lethal factorP15917Details
Dual specificity mitogen-activated protein kinase kinase 2P36507Details